INTRODUCTION
The implementation of genomebased platforms to characterize gene expression marked a new era in modern biology (reviewed in Reference 1). In the post-genomic era, there has been a major effort to characterize the gene expression profiles of different cells and tissues and also to investigate gene expression networks. Posttranscriptional regulation of gene expression plays a pivotal role in determining the quality and quantity of protein expression (2) . RNA-binding proteins are the principal regulators of posttranscriptional events, which include pre-messenger RNA (pre-mRNA) splicing, mRNA transport and localization, and mRNA stability and translation (3) . Using genomic technologies to characterize RNA subpopulations associated with specific RNA-binding proteins will help provide a better understanding of biological processes, including development and tumorigenesis (4) .
Identifying the endogenous mRNA or pre-mRNA targets of RNA-binding proteins involved in different regulatory steps of mammalian cells has been challenging and has primarily been limited to in vitro-based methods (5-7). More recently, our laboratory and other laboratories have used in vivo methods to immunoprecipitate and purify endogenous ribonucleoprotein (RNP) complexes and employed genomic technologies to identify RNA targets en masse in a quantitative manner (8) (9) (10) (11) (12) (13) . Although useful for determining RNA-binding protein targets, the current methodologies present technical challenges. For example, background signals and/or false positives that may be generated by nonspecific or, in some cases, specific binding of RNA to beads or antibodies (14), as well as inefficient RNA recovery because of low affinity antibodies. In order to address these and related issues, we designed an approach based on the use of small biotin acceptor peptides (BAP) to tag RNA-binding proteins and streptavidin-Sepharose ® beads to purify the RNP complexes for subsequent gene expression profiling. The interaction between avidin and biotin is recognized for its high specificity and affinity, and as demonstrated in this study, it is highly advantageous for RNP and RNA recovery from cell extracts.
MATERIALS AND METHODS

Cell Lines and Media
293T cells were obtained from ATCC (Manassas, VA, USA) and maintained in Dulbecco's modified Eagle medium (DMEM; Invitrogen, Carlsbad, Ca, USA) supplemented with 10% fetal bovine serum and antibiotics. Cells were plated in 150-mm dishes coated with 0.001% poly-L-lysine (Sigma, St. Louis, MO, USA).
Plasmid Construction
BirA, the open reading frame (ORF) of the Escherichia coli BirA gene was cloned by PCR from E. coli genomic DNA and introduced into the pcDNA3 vector (Invitrogen). pSHREKK was generated by inserting into pcDNA3 a double-stranded oligonucleotide containing the sequence that encodes the peptide MSGLNDIFEAQKIEWHE. This sequence is based on the BAP #85 (15). BAP-poly(A)-binding protein (PABP) was prepared by inserting the sequence encoding the peptide recognized by the tobacco etch virus (TEV) protease (ENLYFQG) followed by the poly(A)-binding protein I (PABP-I) ORF into pSHREKK (upstream BAP). BAP-human transformer 2 (hTra-2) was constructed identically to the BAP-PABP clone but using the human transformer-2β isoform ORF included in place of the PABP-I sequence. PEGFP-N1 (BD Biosciences Clontech, Palo Alto, CA, USA) was used as a control.
Transient Transfection of 293T Cells
Eight micrograms DNA were used to transfect 293T cells plated as described above. At the time of transfection, cells were typically 50%-60% confluent. Transfections were carried out following the conditions described in GeneJammer™ (Stratagene, La Jolla, CA, USA) instruction booklet. Biotin (Sigma) was added to the medium at the time of transfection.
Western Blot Analysis
Fifty micrograms extract were fractionated by electrophoresis in 4%-20% polyacrylamide sodium dodecyl sulfate (SDS) Laemmli gels. Proteins were transferred to nitrocellulose membranes using a transfer cell (Bio-Rad Laboratories, Hercules, CA, USA SHORT TECHNICAL REPORTS line (PBS) buffer, the membranes were incubated with 1:1000 diluted streptavidin conjugated with horseradish peroxidase (HRP; Chemicon, Temecula, CA, USA). Alternatively, the membranes were incubated with anti-PABP rabbit serum (1:1000 dilution). Antirabbit HRP immunoglobulin G (IgG; Amersham Biosciences, Piscataway, NJ, USA) was used as secondary antibody at a 1:10,000 dilution. Blots were washed with PBS-0.1% Tween 20, developed using electrochemiluminescent (ECL™) detection kits (Amersham Biosciences), and exposed to film.
Preparation of Cell Lysates from 293T Transfected Cells
Forty-eight hours after transfection, cells were washed twice with ice-cold PBS, harvested using a scraper, and pelleted by centrifugation at 1500-2000× g for 5 min at 4°C. The cell pellet was resuspended and homogenized in 1.5 volumes of lysis buffer [100 mM KCl, 25 mM EDTA, 5 mM MgCl 2 , 10 mM HEPES, pH 7.0, 0.5% Nonidet ® P-40 (NP40), 10% glycerol, 2 mM dithiotreitol (DTT), 0.4 mM vanadyl ribonucleoside complex (VRCs; New England Biolabs, Beverly, MA, USA), 1 tablet of Complete Proteinase Inhibitor (Roche, Basel, Switzerland)/50 mL buffer, and 100 U/mL RNaseOUT™ (Invitrogen)]. The lysate was centrifuged at 13,000× g in a microfuge for 10 min at 4°C. The supernatant was transferred to a new tube, and the pellet was treated as before, but this time using only one volume of lysis buffer. The supernatants were combined and stored at -80°C in aliquots of 400 μL (16). 293T cell lysates produced by this method typically range in concentration from 15-20 mg/mL of total protein.
RNP Purification and RNA Preparation
The 400-μL lysate samples were centrifuged in a microfuge at 13,000× g for 10 min at 4°C. The supernatants were transferred to new tubes containing 10 volumes of NT2 buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM MgCl 2 , 0.05% NP40) plus 25 mM EDTA, 2 mM DTT, 100 U/mL RNaseOut, and 0.4 mM VRC. Packed streptavidin-Sepharose beads (125-150 μL; Amersham Biosciences) were resuspended in 10 volumes of NT2 buffer supplemented with 5% bovine serum albumin (BSA) and incubated for 30 min at 4°C. Beads were washed three times with 10 volumes of NT2 buffer and subsequently added to the diluted lysates. Precipitation reactions were tumbled end-over-end at room temperature for 3 h. Following the incubation, the beads were centrifuged for 2 min at 1000-1500× g at 4°C and washed with approximately 10 bead volumes of icecold NT2 buffer. This operation was repeated four more times. The beads were then resuspended in 400 μL of 1× TEV protease buffer containing 40 U TEV protease (Invitrogen). The digestions were performed in a hybridization oven for 2 h at 30°C. After incubation, 400 μL of 2× proteinase K digestion mixture (100 mM Tris, pH 7.5, 10 mM EDTA, 50 mM NaCl, 1% SDS, 500 μg proteinase K) were added to the tubes. Reactions were placed back into the hybridization oven and tumbled for additional 30 min at 50°C. Beads were centrifuged at 1500-2000× g for 3 min at 4°C and the supernatants were transferred to new tubes containing 700 μL of phenol-chloroform. Samples were vortex mixed for 30 s and centrifuged at 13,000× g for 5 min at 4°C. The extraction was repeated with one volume of chloroform. RNA was precipitated by the addition of 0.8 volumes of isopropanol, 80 μL 4 M ammonium acetate, 3 μL 1 M MgCl 2, and 8 μL glycogen 20 mg/mL (Roche). Samples were stored at -80°C until ready for gene expression analysis. RNA was recovered by centrifugation (13,000× g for 30 min at 4°C), washed with 100 μL of 80% ethanol, and resuspended in water or hybridization buffer depending on the gene expression analysis method that will be performed.
Gene Expression Analysis
RNase protection assays (RPAs). Precipitated RNAs were assayed by RNase protection using the RiboQuant™ assay (BD Biosciences Pharmingen, San Diego, CA, USA) according to the manufacturer's recommendations (45014K). The human tumor suppressor (hTS1) template set (556161) was used in the experiment shown here. Protected riboprobe fragments were visualized on a phosphorimaging screen. Phosphorimages were scanned using the Storm™ 860 system (Amersham Biosciences) at 100 μm resolution and analyzed by using ImageQuant™ software (ver. 5.0).
Atlas™ microarrays. cDNA array analysis was performed by using Atlas Human 1.2 Arrays (BD Biosciences Clontech). Probing of cDNA arrays was performed as described in the Atlas cDNA Expression Arrays user's manual. Reverse-transcribed probes were radiolabeled using [α-32 P]dATP (Amersham Biosciences). After hybridization, each array membrane was washed, and the results were visualized by phospho- SHORT TECHNICAL REPORTS rimaging as described above. Images were analyzed using Atlas Image 2.01 software (BD Biosciences Clontech).
RESULTS AND DISCUSSION
To demonstrate the effectiveness and flexibility of this method, we chose a cytoplasmic RNA-binding protein (PABP I) and a nuclear protein (hTra-2), which play roles in translation and splicing, respectively (20,21). The presence of the BAP tags did not affect cellular localization of PABP and hTra-2 in comparison to wild-type proteins (data not shown). Figure 1 represents a schematic view of this methodology. 293T cells were transiently cotransfected with constructs expressing BAP-tagged RNA-binding proteins and the E. coli BirA enzyme, which catalyzes the biotinylation process in vivo (19). Cell extracts were prepared 48 h posttransfection. The RNP complexes are then purified by precipitation with streptavidin-Sepharose beads. As part of the strategy to decrease the background due to nonspecific binding of RNA to the beads, we introduced a TEV NIa protease recognition sequence between the RNA-binding protein and the BAP tag (22). After precipitation, the beads were washed, resuspended in protease buffer, and digested with TEV, thereby releasing the RNPs into the supernatant. The beads were centrifuged and discarded. RNAs are extracted, precipitated, and analyzed using microarrays or RNase protection assays. See Materials and Methods for a more detailed description.
We initially assessed by Western blot analysis the specificity and efficiency of the biotinylation reaction. The major concern was the biotinylation of other endogenous RNA-binding proteins that could present a problem by generating false positives. No biotinylated products other than the transfected BAP-RNA-binding proteins were detected under these conditions, and as expected, both BAP-PABP and BAP-hTra-2 were biotinylated only when the BirA product was co-expressed ( Figure 2, A and B) . Moreover, biotinylation was dramatically enhanced when additional biotin (100 or 1000 μM) was added to the medium. Compare Figure 2A lane 3 (no added biotin) to lane 4 (100 μM biotin) and lane 5 (1000 μM biotin).
We next tested the efficiency of biotinylation by binding BAP-PABP in 293T extracts to streptavidin-Sepharose beads ( Figure 2C) . Nonbiotinylated BAP-PABP should not bind steptavidin and consequently is expected to remain in the supernatant. Comparison of the material eluted from the beads (lane 4) to the supernatant (lane 3) and to the input (lane 2) showed that almost all BAP-PABP was biotinylated and that it could also be efficiently recovered using streptavidin-Sepharose beads. Similar recoveries were reported previously using a mammalian transcription factor (19).
In order to evaluate the efficiency of RNA recovery, specificity and background using this methodology, we cotransfected 293T cells with either the BAP-PABP or BAP-hTra2 constructs in combination with constructs encoding either the BirA enzyme or control green fluorescent protein (GFP). Cell extracts and precipitations were performed as described above. RNA samples were analyzed by both multiprobe RPAs ( Figure 3A) and Atlas cDNA microarrays ( Figure 3B ). Protein A-tagged PABP was used as a positive control. As can be seen in Figure 3 , mRNAs were recovered and detected only when the BirA enzyme was co-expressed with the tagged RNA-binding protein. Minimal background was observed when GFP was substituted in place of BirA. Moreover, when the BAP-RNA-binding protein was substituted with control GFP, no RNA products were detected ( Figure 3A and data not shown) . This result suggests that if other endogenous RNA-binding proteins were biotinylated, any associated mRNAs represented in the probe set were below background detection. A detailed analysis of the microarray data shown in Figure 3B (BAP -PABP + BirA × BAB -PABP + GFP) is provided as supplementary material found on the BioTechniques' web site at http://BioTechniques.com/Oct04/ PenalvaSupplementary.html.
In conclusion, the methodology described here provides a high affinity alternative for biochemical characterization of RNP complexes and can be used with animal models for gene expression profiling of specific cell types in tissues or tumors (4,7,8) . 
INTRODUCTION
The pronuclear microinjection technique has been used as an important tool for the production of transgenic animals. However, this procedure is characterized by random integration of the transgene, usually as multiple copies in tandem that vary in number between transgenic lines (1). Traditionally, the transgene copy number in both founders and G1 hemizygous transgenic mice has been analyzed by blotting techniques (i.e., Southern blot analysis, dot blot, and slot blot), which are tedious and time-consuming methods that require a large amount of DNA sample for each assay. Moreover, the quantification by those methods is not accurate and gives ambiguous results.
With the emergence of the real-time quantitative PCR technology, different applications have been described for the analysis of transgenic organisms, such as the determination of transgene copy number in transformed plants (2) or the study of zygosity in transgenic animals (3, 4) .
Here we present a new application of the real-time quantitative PCR for transgene copy number determination in transgenic animals, characterized by the speed, high-throughput, sensitivity, and accuracy of the TaqMan ® methodology (5, 6) . For this purpose, we used the 2 -∆∆Ct method (7) to compare the ΔC t [cycle threshold (C t ); C t of target minus C t of control gene] value of transgenic animal samples with unknown transgene copy numbers with the ΔCt of a known calibrator. Unlike the approach used by Tesson et al. (3) , the use of a control sample previously analyzed by Southern blot analysis is not required in the current method. A goat genomic DNA sample, carrying a single copy of the β-Lactoglobulin (βLG) gene, was used as a calibrator to determine the transgene copy number in several caprine βLG transgenic mice lines. Moreover, we describe the primers and TaqMan probe design that amplify with the same efficiency and sensitivity a highly conserved sequence of the glucagon gene in goat as in mouse samples that can be used for endogenous control gene amplification in both species.
MATERIALS AND METHODS
Animals and DNA Samples
Transgenic mice were previously generated by pronuclear microinjection of the pPX(7.0) construct, which con- 
